Krüppel-like factor 3 (KLF3/BKLF) is required for widespread repression of the inflammatory modulator galectin-3 (Lgals3)

Journal of Biological Chemistry

Volumn 291, Issue 31, 2016, Pages 16048-16058

  Knights, Alexander J ^a   Yik, Jinfen J ^a   Jusoh, Hanapi Mat ^b   Norton, Laura J ^a   Funnell, Alister P W ^a   Pearson, Richard C M ^a   Bell Anderson, Kim S ^b   Crossley, Merlin ^a   Quinlan, Kate G R ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINS; BIOCHEMISTRY; CELL DEATH; GENES; MAMMALS; PATHOLOGY; PROTEINS;

BIOLOGICAL PROCESS; C-TERMINAL-BINDING PROTEINS; IMMUNOPRECIPITATIONS; METABOLIC DISORDERS; MOLECULAR ANALYSIS; THERAPEUTIC INTERVENTION; TRANSCRIPTIONAL LEVELS; ZINC FINGER TRANSCRIPTION FACTOR;

TRANSCRIPTION;

C TERMINAL BINDING PROTEIN; GALECTIN 3; KRUPPEL LIKE 3; KRUPPEL LIKE FACTOR; MESSENGER RNA; REPRESSOR PROTEIN; UNCLASSIFIED DRUG; AUTACOID; KLF3 PROTEIN, MOUSE; LGALS3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE REPRESSION; GENE SILENCING; KNOCKOUT MOUSE; LECTIN GALACTOSIDE BINDING SOLUBLE 3 GENE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TISSUE DISTRIBUTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ANIMALS; GALECTIN 3; GENE SILENCING; INFLAMMATION MEDIATORS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; REPRESSOR PROTEINS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 84979741914     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M116.715748     Document Type: Article

References (50)

1. Dagher, S. F., Wang, J. L., and Patterson, R. J. (1995) Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. Natl. Acad. Sci. U.S.A. 92, 1213-1217
2. MacKinnon, A. C., Farnworth, S. L., Hodkinson, P. S., Henderson, N. C., Atkinson, K. M., Leffler, H., Nilsson, U. J., Haslett, C., Forbes, S. J., and Sethi, T. (2008) Regulation of alternative macrophage activation by galectin-3. J. Immunol. 180, 2650-2658
3. Elad-Sfadia, G., Haklai, R., Balan, E., and Kloog, Y. (2004) Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity. J. Biol. Chem. 279, 34922-34930
4. Yang, R. Y., Hsu, D. K., and Liu, F. T. (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 93, 6737-6742
5. de Boer, R. A., Voors, A. A., Muntendam, P., van Gilst, W. H., and van Veldhuisen, D. J. (2009) Galectin-3: a novel mediator of heart failure development and progression. Eur. J. Heart Fail. 11, 811-817
6. Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J., and Sethi, T. (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 103, 5060-5065
7. Srivatsan, V., George, M., and Shanmugam, E. (2015) Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand? Eur. J. Prev. Cardiol. 22, 1096-1110
8. Karlsen, A. E., Størling, Z. M., Sparre, T., Larsen, M. R., Mahmood, A., Størling, J., Roepstorff, P., Wrzesinski, K., Larsen, P. M., Fey, S., Nielsen, K., Heding, P., Ricordi, C., Johannesen, J., Kristiansen, O. P., et al. (2006) Immune-mediated beta-cell destruction in vitro and in vivo-A pivotal role for galectin-3. Biochem. Biophys. Res. Commun. 344, 406-415
9. Iacobini, C., Menini, S., Oddi, G., Ricci, C., Amadio, L., Pricci, F., Olivieri, A., Sorcini, M., Di Mario, U., Pesce, C., and Pugliese, G. (2004) Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB J. 18, 1773-1775
10. Pearson, R., Fleetwood, J., Eaton, S., Crossley, M., and Bao, S. (2008) Kruppel-like transcription factors: a functional family. Int. J. Biochem. Cell Biol. 40, 1996-2001
11. Pearson, R. C., Funnell, A. P., and Crossley, M. (2011) The mammalian zinc finger transcription factor Kruppel-like factor 3 (KLF3/BKLF). IUBMB Life 63, 86-93
12. Kaushik, D. K., Gupta, M., Das, S., and Basu, A. (2010) Kruppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. J. Neuroinflammation 7, 68
13. Rowland, B. D., Bernards, R., and Peeper, D. S. (2005) The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat. Cell Biol. 7, 1074-1082
14. Eaton, S. A., Funnell, A. P., Sue, N., Nicholas, H., Pearson, R. C., and Crossley, M. (2008) A network of Kruppel-like Factors (Klfs). Klf8 is repressed by Klf3 and activated by Klf1 in vivo. J. Biol. Chem. 283, 26937-26947
15. Funnell, A. P., Norton, L. J., Mak, K. S., Burdach, J., Artuz, C. M., Twine, N. A., Wilkins, M. R., Power, C. A., Hung, T. T., Perdomo, J., Koh, P., Bell-Anderson, K. S., Orkin, S. H., Fraser, S. T., Perkins, A. C., et al. (2012) The CACCC-binding protein KLF3/BKLF represses a subset of KLF1/EKLF target genes and is required for proper erythroid maturation in vivo. Mol. Cell. Biol. 32, 3281-3292
16. Crossley, M., Whitelaw, E., Perkins, A., Williams, G., Fujiwara, Y., and Orkin, S. H. (1996) Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Mol. Cell. Biol. 16, 1695-1705
17. Turner, J., and Crossley, M. (1998) Cloning and characterization of mCtBP2, a co-repressor that associates with basic Kruppel-like factor and other mammalian transcriptional regulators. EMBO J. 17, 5129-5140
18. Shi, Y., Sawada, J., Sui, G., Affar el, B., Whetstine, J. R., Lan, F., Ogawa, H., Luke, M. P., Nakatani, Y., and Shi, Y. (2003) Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422, 735-738
19. Ueda, J., Tachibana, M., Ikura, T., and Shinkai, Y. (2006) Zinc finger protein Wiz links G9a/GLP histone methyltransferases to the co-repressor molecule CtBP. J. Biol. Chem. 281, 20120-20128
20. Dewi, V., Kwok, A., Lee, S., Lee, M. M., Tan, Y. M., Nicholas, H. R., Isono, K., Wienert, B., Mak, K. S., Knights, A. J., Quinlan, K. G., Cordwell, S. J., Funnell, A. P., Pearson, R. C., and Crossley, M. (2015) Phosphorylation of Kruppel-like factor 3 (KLF3/BKLF) and C-terminal binding protein 2 (CtBP2) by homeodomain-interacting protein kinase 2 (HIPK2) modulates KLF3 DNA binding and activity. J. Biol. Chem. 290, 8591-8605
21. Perdomo, J., Verger, A., Turner, J., and Crossley, M. (2005) Role for SUMO modification in facilitating transcriptional repression by BKLF. Mol. Cell. Biol. 25, 1549-1559
22. Vu, T. T., Gatto, D., Turner, V., Funnell, A. P., Mak, K. S., Norton, L. J., Kaplan, W., Cowley, M. J., Agenès, F., Kirberg, J., Brink, R., Pearson, R. C., and Crossley, M. (2011) Impaired B cell development in the absence of Kruppel-like factor 3. J. Immunol. 187, 5032-5042
23. Bell-Anderson, K. S., Funnell, A. P., Williams, H., Mat Jusoh, H., Scully, T., Lim, W. F., Burdach, J. G., Mak, K. S., Knights, A. J., Hoy, A. J., Nicholas, H. R., Sainsbury, A., Turner, N., Pearson, R. C., and Crossley, M. (2013) Loss of Kruppel-like factor 3 (KLF3/BKLF) leads to upregulation of the insulin-sensitizing factor adipolin (FAM132A/CTRP12/C1qdc2). Diabetes 62, 2728-2737
24. Sue, N., Jack, B. H., Eaton, S. A., Pearson, R. C., Funnell, A. P., Turner, J., Czolij, R., Denyer, G., Bao, S., Molero-Navajas, J. C., Perkins, A., Fujiwara, Y., Orkin, S. H., Bell-Anderson, K., and Crossley, M. (2008) Targeted disruption of the basic Kruppel-like factor gene (Klf3) reveals a role in adipogenesis. Mol. Cell. Biol. 28, 3967-3978
25. Kelsey, L., Flenniken, A. M., Qu, D., Funnell, A. P., Pearson, R., Zhou, Y. Q., Voronina, I., Berberovic, Z., Wood, G., Newbigging, S., Weiss, E. S., Wong, M., Quach, I., Yeh, S. Y., Deshwar, A. R., et al. (2013) ENU-induced mutation in the DNA-binding domain of KLF3 reveals important roles for KLF3 in cardiovascular development and function in mice. PLoS Genet. 10.1371/journal.pgen.1003612
26. Pang, J., Rhodes, D. H., Pini, M., Akasheh, R. T., Castellanos, K. J., Cabay, R. J., Cooper, D., Perretti, M., and Fantuzzi, G. (2013) Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice. PLoS ONE 10.1371/journal.pone.0057915
27. Pejnovic, N. N., Pantic, J. M., Jovanovic, I. P., Radosavljevic, G. D., Djukic, A. L., Arsenijevic, N. N., and Lukic, M. L. (2013) Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets. Adipocyte 2, 266-271
28. Pejnovic, N. N., Pantic, J. M., Jovanovic, I. P., Radosavljevic, G. D., Milovanovic, M. Z., Nikolic, I. G., Zdravkovic, N. S., Djukic, A. L., Arsenijevic, N. N., and Lukic, M. L. (2013) Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62, 1932-1944
29. Burdach, J., Funnell, A. P., Mak, K. S., Artuz, C. M., Wienert, B., Lim, W. F., Tan, L. Y., Pearson, R. C., and Crossley, M. (2014) Regions outside the DNA-binding domain are critical for proper in vivo specificity of an archetypal zinc finger transcription factor. Nucleic Acids Res. 42, 276-289
30. Ho, M. K., and Springer, T. A. (1982) Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J. Immunol. 128, 1221-1228
31. Courey, A. J., and Tjian, R. (1988) Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55, 887-898
32. Stock, M., Schäfer, H., Stricker, S., Gross, G., Mundlos, S., and Otto, F. (2003) Expression of galectin-3 in skeletal tissues is controlled by Runx2. J. Biol. Chem. 278, 17360-17367
33. Vladimirova, V., Waha, A., Lückerath, K., Pesheva, P., and Probstmeier, R. (2008) Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J. Neurosci. Res. 86, 2450-2461
34. Zhang, H. Y., Jin, L., Stilling, G. A., Ruebel, K. H., Coonse, K., Tanizaki, Y., Raz, A., and Lloyd, R. V. (2009) RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors. Endocrine 35, 101-111
35. Chawla, A., Nguyen, K. D., and Goh, Y. P. (2011) Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11, 738-749
36. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184
37. MacKinnon, A. C., Liu, X., Hadoke, P. W., Miller, M. R., Newby, D. E., and Sethi, T. (2013) Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. Glycobiology 23, 654-663
38. Brownlee, M. (1995) Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46, 223-234
39. Ahmad, T., and Felker, G. M. (2012) Galectin-3 in heart failure: more answers or more questions? J. Am. Heart. Assoc. 10.1161/JAHA.112.004374
40. Kelly, B., and O'Neill, L. A. (2015) Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771-784
41. + and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc. Natl. Acad. Sci. U.S.A. 100, 9202-9207
42. Jack, B. H., Pearson, R. C., and Crossley, M. (2011) C-terminal binding protein: a metabolic sensor implicated in regulating adipogenesis. Int. J. Biochem. Cell Biol. 43, 693-696
43. Zhang, X., Goncalves, R., and Mosser, D. M. (2008) The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 83, 14.1.1-14.1.14
44. Funnell, A. P., Maloney, C. A., Thompson, L. J., Keys, J., Tallack, M., Perkins, A. C., and Crossley, M. (2007) Erythroid Kruppel-like factor directly activates the basic Kruppel-like factor gene in erythroid cells. Mol. Cell. Biol. 27, 2777-2790
45. Hancock, D., Funnell, A., Jack, B., and Johnston, J. (2010) Introducing undergraduate students to real-time PCR. Biochem. Mol. Biol. Educ. 38, 309-316
46. McCloy, R. A., Rogers, S., Caldon, C. E., Lorca, T., Castro, A., and Burgess, A. (2014) Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle 13, 1400-1412
47. Schmidt, D., Wilson, M. D., Spyrou, C., Brown, G. D., Hadfield, J., and Odom, D. T. (2009) ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions. Methods 48, 240-248
48. Encode Project Consortium. (2011) A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 10.1371/journal.pbio.1001046
49. Shen, Y., Yue, F., McCleary, D. F., Ye, Z., Edsall, L., Kuan, S., Wagner, U., Dixon, J., Lee, L., Lobanenkov, V. V., and Ren, B. (2012) A map of the cis-regulatory sequences in the mouse genome. Nature 488, 116-120
50. Neph, S., Stergachis, A. B., Reynolds, A., Sandstrom, R., Borenstein, E., and Stamatoyannopoulos, J. A. (2012) Circuitry and dynamics of human transcription factor regulatory networks. Cell 150, 1274-1286